About Hexagon Bio
Hexagon Bio is a company based in Menlo Park (United States) founded in 2017.. Hexagon Bio has raised $205.6 million across 5 funding rounds from investors including CPP Investments, SoftBank Vision Fund and The Column Group. The company has 34 employees as of December 31, 2020. Hexagon Bio offers products and services including Science Platform and Antibody Drug Conjugates. Hexagon Bio operates in a competitive market with competitors including Strand Life Sciences, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others.
- Headquarter Menlo Park, United States
- Employees 34 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Hexagon Bio, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$205.6 M (USD)
in 5 rounds
-
Latest Funding Round
$77.3 M (USD), Series B
Sep 30, 2022
-
Investors
CPP Investments
& 6 more
-
Employee Count
34
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Hexagon Bio
Hexagon Bio offers a comprehensive portfolio of products and services, including Science Platform and Antibody Drug Conjugates. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for mining genomes and developing novel ADC payloads using computation.
Solutions for creating next-generation cancer treatments with orthogonal mechanisms.
Unlock access to complete
Unlock access to complete
Funding Insights of Hexagon Bio
Hexagon Bio has successfully raised a total of $205.6M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $77.3 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $77.3M
-
First Round
First Round
(16 Jun 2017)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Series B - Hexagon Bio | Valuation |
investors |
|
| Jun, 2021 | Amount | Series B - Hexagon Bio | Valuation | Nextech Invest | |
| Sep, 2020 | Amount | Series A - Hexagon Bio | Valuation | TCG , Two Sigma Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Hexagon Bio
Hexagon Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include CPP Investments, SoftBank Vision Fund and The Column Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location | |
|
Early-stage investments in tech sectors are managed by the firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Hexagon Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Hexagon Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hexagon Bio Comparisons
Competitors of Hexagon Bio
Hexagon Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Genomics, Seven Bridges Genomics, Depixus and Ingenuity Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
New genome engineering technology is provided for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hexagon Bio
Frequently Asked Questions about Hexagon Bio
When was Hexagon Bio founded?
Hexagon Bio was founded in 2017.
Where is Hexagon Bio located?
Hexagon Bio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Hexagon Bio a funded company?
Hexagon Bio is a funded company, having raised a total of $205.6M across 5 funding rounds to date. The company's 1st funding round was a Series A of $47M, raised on Jun 16, 2017.
How many employees does Hexagon Bio have?
As of Dec 31, 2020, the latest employee count at Hexagon Bio is 34.
What does Hexagon Bio do?
Hexagon Bio was founded in 2017 and is based in Menlo Park, United States. Operations focus on the bioinformatics sector, where tools are developed for processing microbial genome sequencing data. Researchers utilize the platform to examine sequencing outputs and pinpoint small-molecule drug candidates for therapeutic uses across various applications. Services emphasize data analysis support in biotechnology and pharmaceuticals.
Who are the top competitors of Hexagon Bio?
Hexagon Bio's top competitors include Strand Life Sciences, Tessera Therapeutics and Phase Genomics.
What products or services does Hexagon Bio offer?
Hexagon Bio offers Science Platform and Antibody Drug Conjugates.
Who are Hexagon Bio's investors?
Hexagon Bio has 7 investors. Key investors include CPP Investments, SoftBank Vision Fund, The Column Group, Two Sigma Ventures, and 8VC.